Antiviral study for COVID-19 patients seeking participants

Dr James McMahon is leading a study to find out whether an

antiviral called favipiravir will help people with COVID-19

clear the virus from their systems faster. Video explainer

Researchers from The Alfred and Monash University have set out to determine whether an antiviral medication that has been previously studied in people with influenza and other viral infections will help people with COVID-19 recover faster.

Lead researcher and Infectious Diseases specialist Dr James McMahon said the antiviral, Favipiravir, is being studied in multiple countries including the United States and Japan, where it was first developed to treat people with influenza. It is being studied in a number of trials globally to see if it could help clear the COVID-19 virus faster.